Actually, re-reading this press release enrages me. They are spinning this like it’s a positive: “...one step closer to approval”. Even just a regular small time investor in US pharma/biotech knows that receipt of a CRL from the FDA is the worst possible outcome. A CRL is a formal decision not a step in the process, and Scott well knows this. Most stocks get absolutely smashed after a CRL - in recent months I’ve seen anywhere from 50-80% plunges in the share price within minutes of news that a CRL has been issued. For many drug companies it’s the end of the road for that drug.
What planet is Mayne on here? I like optimism but I don’t appreciate bullish!t dressed up as tinsel.
- Forums
- ASX - By Stock
- MYX
- Ann: MAYNE PHARMA provides FDA update on generic NUVARING
MYX
mayne pharma group limited
Add to My Watchlist
0.38%
!
$5.23

Ann: MAYNE PHARMA provides FDA update on generic NUVARING, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.23 |
Change
-0.020(0.38%) |
Mkt cap ! $430.6M |
Open | High | Low | Value | Volume |
$5.25 | $5.30 | $5.23 | $369.2K | 69.89K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1300 | $5.22 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.25 | 2070 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 3656 | 5.250 |
2 | 651 | 5.240 |
4 | 2689 | 5.230 |
3 | 1903 | 5.220 |
2 | 928 | 5.210 |
Price($) | Vol. | No. |
---|---|---|
5.260 | 1913 | 8 |
5.270 | 1152 | 4 |
5.280 | 1555 | 4 |
5.290 | 2298 | 5 |
5.300 | 1467 | 4 |
Last trade - 11.15am 28/07/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online